One-level anterior cervical discectomy and fusion can be safely performed in an outpatient setting, according to a study published in the Journal of Spinal Disorders & Techniques.
The Latest
Medtronic has received FDA 510(k) clearance for the Kyphon Xpander II inflatable bone tamp for treating vertebral compression fractures with the minimally invasive Kyphon balloon kyphoplasty, according to a company news release.
Merlot OrthopediX, a Cleveland Clinic spin-off company dedicated to spine surgery innovation, has entered into an exclusive agreement with Alphatec Spine to develop and commercialize bone anchorage technology for the spine, according to a Merlot OrthopediX news release.
One of the many options for orthopedic surgeons partnering with hospitals is co-management. Co-management agreements allow physician CEOs to govern a hospital's orthopedic service line while the hospital supports the surgeons and their practices. "Co-management agreements transform the relationship between…
The use of platelet rich plasma is still a relatively new treatment for orthopedic patients. However physicians are increasingly using PRP as an alternative to medication and surgery for patients with pain. Here are seven things orthopedic surgeons should know…
The American Academy of Orthopaedic Surgeons reported that women represent 3.9 percent of orthopedic surgeons and 13.8 percent of orthopedic residents, according to a Newswise report.
The University of Interscholastic League in Austin, Texas, unanimously approved new guidelines for athletes with concussions, according to a KBTX report.
The World Anti-Doping Agency has approved the 2011 list of prohibited substances and methods, which added a "Non-Approved Substances" section and removed platelet rich plasma from the prohibited procedures, according to an organization news release.
Kensey Nash, an Exton, Pa., medical device company, reported a net sales of $10.9 million for the first quarter of fiscal year 2011, a decrease from last year's first quarter net sales report of $13.4 million, according to a company…
Johnson & Johnson announced sales of $15 billion for the third quarter of 2010, a decrease of 0.7 percent from the third quarter of 2009, according to a company news release.